1429176-23-7

Basic information

• Product Name: (S)-3-(2-((S)-1-(3,4-dichlorophenyl)ethylamino)pyrimidin-4-yl)-4-isopropyloxazolidin-2-one
• Synonyms: (S)-3-(2-((S)-1-(3,4-dichlorophenyl)ethylamino)pyrimidin-4-yl)-4-isopropyloxazolidin-2-one
• CAS NO: 1429176-23-7
• Molecular Weight: 395.288
• Mol File: 1429176-23-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-3-(2-((S)-1-(3,4-dichlorophenyl)ethylamino)pyrimidin-4-yl)-4-isopropyloxazolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3-(2-((S)-1-(3,4-dichlorophenyl)ethylamino)pyrimidin-4-yl)-4-isopropyloxazolidin-2-one(1429176-23-7)
• EPA Substance Registry System: (S)-3-(2-((S)-1-(3,4-dichlorophenyl)ethylamino)pyrimidin-4-yl)-4-isopropyloxazolidin-2-one(1429176-23-7)

Safety Data

• Hazardous Substances Data: 1429176-23-7(Hazardous Substances Data)

Upstream product

• 1429180-81-3 (S)-3-(2-chloropyrimidin-4-yl)-4-isopropyl-oxazolidin-2-one 
• 74877-07-9 1-(S)-(-)-(3,4-dichlorophenyl)-ethylamine 

Relevant articles and documents

3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH

The invention is directed to a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1-R6 are defined herein. The invention is also directed to compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. The invention is further directed to the use of a compound of formual (I) in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer